Spravato (esketamine)

The FDA approval of Spravato is a breakthrough for treatment-resistant depression, offering patients rapid relief. The U.S. Food and Drug Administration (FDA) has officially approved Spravato (esketamine) nasal spray as a standalone treatment for adults with treatment-resistant depression (TRD). This groundbreaking decision marks a new chapter in...

Cutting-edge depression treatments like TMS and Spravato (esketamine) are changing lives, offering renewed hope for those who haven’t found relief through traditional methods. In the evolving landscape of emotional wellness care, cutting-edge depression treatments are offering new hope to millions of people living with major depressive...

For many patients, the effects of Spravato are noticeable within days or weeks, offering a faster path to feeling like yourself again. For those grappling with treatment-resistant depression (TRD), finding an effective solution can feel like a never-ending journey. Traditional treatments, including antidepressants and therapy, don’t always...

For those with treatment-resistant depression, breakthroughs like TMS and Spravato are not just treatments—they’re lifelines. Depression affects more than just your mood—it touches every aspect of life, from work and relationships to physical health. When left untreated, depression can have hidden costs that extend far beyond...

Spravato (esketamine) at Sonder is a safe, effective, and personalized treatment option for those whose depression has not responded to other approaches. Spravato (esketamine) has garnered attention as a groundbreaking treatment for depression, particularly for those who have tried other treatment approaches with insufficient results. Whether you’re...

Sonder is proud to introduce Spravato (esketamine), a groundbreaking treatment option for those who haven’t found relief through traditional antidepressants. Are you or someone you care about struggling with treatment-resistant depression? We have exciting news to share! Sonder is proud to introduce Spravato (esketamine), a groundbreaking treatment option...